Global Small Animal Imaging (In-vivo) Market By Component (Micro-MRI, Optical Imaging, Nuclear Imaging), Application (Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies, Epigenetics)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Small Animal Imaging (In-vivo) Market
Market Report Description
The Global small animal imaging (in-vivo) market size is expected to reach $2.7 billion by 2022, growing at CAGR of 10.7% from 2016 to 2022. Small animal imaging (in-vivo) devices are an emerging diagnoses solution used for variety of diseases found across laboratory animals. A wide range of small animal imaging (in-vivo) devices are majorly used in wide range of domains, namely cancer cell research, monitoring drug response during drug development, assessing the bio-distribution patterns of new chemical entities, biomarker research in animal models, in longitudinal studies and others. These devices have gained prominence and are majorly being used in epigenetic research studies, receptor targeting, and defining mechanism of action.
The growth of the small animal imaging (in-vivo) market is driven due to multi-functional pre-clinical imaging, investments by clinical research organizations (CROs) in pre-clinical studies, growing number of pharmaceutical and research based organizations and technical breakthroughs such as high-resolution MRI with other imaging modalities. Stringent government regulations, inadequate reimbursement policies, accuracy and high cost of the devices are the factors that would hinder the market growth during the forecast period. The report highlights the adoption of Small Animal Imaging (In-vivo) Market, globally.
Based on the Technology, the Global Small Animal Imaging (In-vivo) Market is segmented into Micro-MRI, Optical Imaging, Nuclear Imaging and Others (Micro-Ultrasound and micro-CT) segment. Based on the Application, the market is bifurcated into Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics segments. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Key players profiled in the report includes Thermo Fisher Scientific Inc., Mediso Medical Imaging Systems, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., Siemens AG and Fujifilm Holdings Corporation.